PATADAY™ (olopatadine hydrochloride ophthalmic solution) 0.2% is a sterile ophthalmic solution containing olopatadine for topical administration to the eyes.
PATADAY™ solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
Published Studies Related to Pataday (Olopatadine Ophthalmic)
Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic
rhinitis: A randomized, double-blind, placebo-controlled study. 
Adequate treatment is critical for maintaining a good level of quality of life
(QOL) during the pollen season in patients suffering from seasonal allergic
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2009.08]
PURPOSE: We aimed to compare the clinical efficacy and ocular surface variables of olopatadine, ketotifen fumarate, epinastine, emedastine and fluorometholone acetate ophthalmic solutions in preventing the signs and symptoms of seasonal allergic conjunctivitis (SAC)... CONCLUSIONS: In patients with SAC, olopatadine, ketotifen, epinastine and emedastine are more efficacious than fluorometholone acetate in preventing itching and redness. All the antiallergic agents gave similar results in terms of reducing tearing, chemosis and eyelid swelling. Our data showed that impression cytology parameters improved after treatment with antiallergic agents in patients with SAC.
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2008.07.08]
Purpose: We aimed to compare the clinical efficacy and ocular surface variables of olopatadine, ketotifen fumarate, epinastine, emedastine and fluorometholone acetate ophthalmic solutions in preventing the signs and symptoms of seasonal allergic conjunctivitis (SAC)... Our data showed that impression cytology parameters improved after treatment with antiallergic agents in patients with SAC.
Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye. [2008.02]
PURPOSE: Olopatadine hydrochloride 0.2% (Pataday, Alcon, Fort Worth, USA) is a topical ocular anti-allergic agent that has shown high rates of efficacy in treating ocular itching, the primary symptom of allergic conjunctivitis, and allows for once-daily dosing. Since some patients suffer from signs or symptoms of dry eye in addition to ocular allergy, this study was designed to evaluate the safety of olopatadine 0.2% in a population of patients with both allergic conjunctivitis and dry eye... CONCLUSION: As there were no significant changes in the signs and symptoms of dry eye, olopatadine hydrochloride 0.2% is safe to use in ocular allergy patients with mild-to-moderate dry eye.
Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge. [2007.12]
Olopatadine 0.1% (Patanol) and olopatadine 0.2% (Pataday) ophthalmic solutions are topical ocular anti-allergic agents with antihistaminic and mast cell stabilizing properties. The efficacy of two doses of olopatadine 0.1% was compared to one dose of olopatadine 0.2% in the prevention of ocular itching associated with allergic conjunctivitis over 24 hours...
Clinical Trials Related to Pataday (Olopatadine Ophthalmic)
Comparing Patient Satisfaction With Pataday or Bepreve [Recruiting]
The purpose of this study is to compare patient satisfaction with Pataday (Olopatadine
hydrochloride 0. 2%) one daily (QD) and Bepreve (Bepotastine besilate ophthalmic solution
1. 5%) two times a day (BID).
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis [Recruiting]
The purpose of this study is to evaluate an ophthalmic solution for the treatment of ocular
itching associated with allergic conjunctivitis using the Conjunctival Allergen Challenge
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients [Recruiting]
Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis [Not yet recruiting]
The purpose of this study is to evaluate the clinical efficacy of the ophthalmic solution
PRO-118 compared with olopatadine hydrochloride ophthalmic solution in allergic
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age [Recruiting]
The purpose of the study is to assess the safety of the study drug, Patanase (Olopatadine
Hydrochloride Nasal Spray 0. 6%) compared to placebo (inactive substance) in children ages 2
to less than 6 who have a history of nasal allergies, and to assess the pharmcokinetics
(study of the action of a drug in the body) in these children
Reports of Suspected Pataday (Olopatadine Ophthalmic) Side Effects
Oropharyngeal Pain (2),
Drug Hypersensitivity (2),
Influenza Like Illness (1),
Rash Pruritic (1),
Back Pain (1), more >>
PATIENT REVIEWS / RATINGS / COMMENTS
Based on a total of 1 ratings/reviews, Pataday has an overall score of 9. The effectiveness score is 10 and the side effect score is 10. The scores are on ten point scale: 10 - best, 1 - worst.
Pataday review by 48 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Highly Effective|
|Side effects:|| || No Side Effects|
|Condition / reason:|| || allergic reaction|
|Dosage & duration:|| || 1-2 drops a day (dosage frequency: daily) for the period of unlimited|
|Other conditions:|| || dry eyes|
|Other drugs taken:|| || restasis|
|Benefits:|| || taking the eye drops once a day relieved itching and redness. there were no side effects. the treatment stopped my eyes from itching and being red. it did not seem to have any other side effects. there is really nothing else to say about it.|
|Side effects:|| || there were no side effects|
|Comments:|| || once a day, usually in the morning put 1-2 drops in each eye|
Page last updated: 2013-02-10